Post job

Crinetics Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Scott R. Struthers is the Crinetics Pharmaceuticals's CEO. Crinetics Pharmaceuticals has 50 employees, of which 98 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Crinetics Pharmaceuticals executive team is 58% female and 42% male.
  • 48% of the management team is White.
  • 20% of Crinetics Pharmaceuticals management is Hispanic or Latino.
  • 8% of the management team is Black or African American.
Work at Crinetics Pharmaceuticals?
Share your experience

Rate Crinetics Pharmaceuticals' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Scott R. Struthers

Founder, CEO

Scott R. Struthers's LinkedIn

New drugs that make a differenceSpecialties: Drug Discovery & Development;Accretion & Development of Biotech Talent;Research: Neuroendocrinology, Structural Pharmacology, Medicinal Chemistry, Reproductive Medicine, Endocrinology, Biophysics & Computational Chemistry, Receptor Pharmacology & Biology

Alan Seth Krasner

Chief Medical Officer

Alan Seth Krasner's LinkedIn

Dr. Alan S. Krasner serves as our Chief Medical Officer. Prior to joining Biodel, Dr. Krasner served as Director in the Department of Clinical Research, Metabolic Diseases at Pfizer Global Research and Development, where he was responsible for the design, execution, clinical analysis, and reporting of multiple, global clinical trials supporting registration of late stage drug candidates. Dr. Krasner is also a consulting physician at the Joslin Diabetes and Endocrinology Center of the Lawrence and Memorial Hospital in New London, Connecticut. Dr. Krasner received a B.S. from Northwestern University where he was in an Honors Program in medical education and an M.D. from Northwestern University Medical School. Dr. Krasner completed his residency at Johns Hopkins Hospital in internal medicine and subsequently received a fellowship from Johns Hopkins Hospital in endocrinology and metabolism.

Stephen F. Betz

Chief Scientific Officer

Stephen F. Betz's LinkedIn

Yun Zhu

Founder

Matthew K. Fust

Board Member

Matthew K. Fust's LinkedIn

Wendell D. Wierenga

Chairman of The Board

Jeff E. Knight

Chief Operating Officer

Garlan Adams

General Counsel

Garlan Adams's LinkedIn

Alyea Ally

Senior Manager

Anna Covington

Board Member

Do you work at Crinetics Pharmaceuticals?

Does the leadership team provide a clear direction for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals jobs

Crinetics Pharmaceuticals founders

Name & TitleBio
Scott R. Struthers

Founder, CEO

Scott R. Struthers's LinkedIn

New drugs that make a differenceSpecialties: Drug Discovery & Development;Accretion & Development of Biotech Talent;Research: Neuroendocrinology, Structural Pharmacology, Medicinal Chemistry, Reproductive Medicine, Endocrinology, Biophysics & Computational Chemistry, Receptor Pharmacology & Biology

Alan Seth Krasner

Chief Medical Officer

Alan Seth Krasner's LinkedIn

Dr. Alan S. Krasner serves as our Chief Medical Officer. Prior to joining Biodel, Dr. Krasner served as Director in the Department of Clinical Research, Metabolic Diseases at Pfizer Global Research and Development, where he was responsible for the design, execution, clinical analysis, and reporting of multiple, global clinical trials supporting registration of late stage drug candidates. Dr. Krasner is also a consulting physician at the Joslin Diabetes and Endocrinology Center of the Lawrence and Memorial Hospital in New London, Connecticut. Dr. Krasner received a B.S. from Northwestern University where he was in an Honors Program in medical education and an M.D. from Northwestern University Medical School. Dr. Krasner completed his residency at Johns Hopkins Hospital in internal medicine and subsequently received a fellowship from Johns Hopkins Hospital in endocrinology and metabolism.

Stephen F. Betz

Chief Scientific Officer

Stephen F. Betz's LinkedIn

Yun Zhu

Founder

Crinetics Pharmaceuticals board members

Name & TitleBio
Scott R. Struthers

Founder, CEO

Scott R. Struthers's LinkedIn

New drugs that make a differenceSpecialties: Drug Discovery & Development;Accretion & Development of Biotech Talent;Research: Neuroendocrinology, Structural Pharmacology, Medicinal Chemistry, Reproductive Medicine, Endocrinology, Biophysics & Computational Chemistry, Receptor Pharmacology & Biology

Matthew K. Fust

Board Member

Matthew K. Fust's LinkedIn

Wendell D. Wierenga

Chairman of The Board

Anna Covington

Board Member

Cosina Mui

Board Member

Elsa Orozco

Board Member

Emmanuel Sturchler

Board Member

Kelsey Retting

Board Member

Michael Johns

Board Member

Nicole Gregory

Board Member

Crinetics Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Crinetics Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Crinetics Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Crinetics Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Crinetics Pharmaceuticals. The data presented on this page does not represent the view of Crinetics Pharmaceuticals and its employees or that of Zippia.

Crinetics Pharmaceuticals may also be known as or be related to CRINETICS PHARMACEUTICALS, INC., Crinetics Pharmaceuticals and Crinetics Pharmaceuticals, Inc.